Navigation Links
Schering-Plough Reports Financial Results for 2009 Second Quarter
Date:7/21/2009

ain other Asian markets) for rheumatoid arthritis, early rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, plaque psoriasis, Crohn's disease, pediatric Crohn's disease and ulcerative colitis.

Global sales of NASONEX, an inhaled nasal corticosteroid for allergies, increased 3 percent to $321 million in the 2009 second quarter (10 percent operational growth offset by 7 percent unfavorable foreign exchange impact) as compared to $311 million in the second quarter of 2008. Operational sales were strong in both the U.S. and internationally as compared to the 2008 period.

Sales of TEMODAR, a treatment for certain types of brain tumors, increased 2 percent (11 percent operational growth offset by 9 percent unfavorable foreign exchange impact) to $256 million, with higher sales in the U.S. and Japan.

Sales of PEGINTRON for hepatitis C decreased 6 percent to $215 million in the 2009 second quarter, primarily due to the unfavorable foreign exchange impact of 6 percent.

In women's health care, sales of FOLLISTIM/PUREGON, a fertility treatment, for the second quarter of 2009 decreased 11 percent (1 percent operational decrease and 10 percent unfavorable foreign exchange impact) to $145 million as compared to the second quarter of 2008. Sales of NUVARING, a contraceptive product, in the second quarter of 2009 increased 11 percent (19 percent operational growth offset by 8 percent unfavorable foreign exchange impact) to $129 million as compared to $116 million in the second quarter of 2008.

Global sales of CLARINEX, a nonsedating antihistamine, were $226 million, a decrease of 6 percent (4 percent operational growth offset by 10 percent unfavorable foreign exchange impact) as compared to the second quarter of 2008.

Sales of CLARITIN in the prescription business were $96 million, a 13 percent decrease (6 percent operational decreas
'/>"/>

SOURCE Schering-Plough Corporation
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27

Related biology technology :

1. PeriCor Therapeutics Announces Closing of Licensing Agreement for Acadesine with Schering-Plough Corporation
2. Schering-Plough Announces Pricing of Senior Notes Offering
3. Schering-Plough to Webcast Presentation at Merrill Lynch Global Pharmaceutical, Biotech & Medtech Conference
4. Schering-Plough Receives Approval from European Commission for Planned Acquisition of Organon BioSciences N.V.
5. Schering-Plough Completes Acquisition of Organon BioSciences
6. Schering-Plough Wins Three of Scrips Top Pharma Industry Awards
7. Schering-Plough Schedules Conference Call and Webcast for 2007 Fourth Quarter, Full-Year Financial Result
8. Schering-Plough to Webcast Presentation at Morgan Stanley Pharmaceutical CEOs Unplugged Conference
9. Schering-Plough Announces New Drug Application for Sugammadex Assigned Priority Review Status by U.S. FDA
10. Schering-Plough Announces Sugammadex New Drug Application Filed in Japan
11. FDA Grants Priority Review for Schering-Ploughs Peginterferon Alfa-2b for the Adjuvant Treatment of Patients With Stage III Melanoma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2013)... 20, 2013 Interventional cardiologist Tony Farah, ... Hospital (AGH) Cardiovascular Institute have helped pioneer many ... disease (CAD) over the past three decades, from ... angioplasty and coronary artery stent implantation. , Today, AGH ... a prominent role in the study of a novel, ...
(Date:5/20/2013)... France (PRWEB) May 20, 2013 On ... this time – in Paris - the beautiful city ... congress chairperson, "Personalized Medicine is revolutionizing the medical world. ... clinical knowledge is the hallmark of this transformation. Much ... care derived from the epidemiologic studies of large cohorts ...
(Date:5/20/2013)... CA (PRWEB) May 20, 2013 The ... announced the appointment of Lisa Baird as Executive Director. ... July 8, 2013. The WMIS vision is ... applications to understand and effectively treat diseases in the ... Society (WMIS) was established in 2011 by integrating the ...
(Date:5/17/2013)... 17, 2013 Topricin Pain Relief ... has been listed among nationally recommended over-the-counter (OTC) ... conducted by "U.S. News" Health in collaboration with ... “No. 1 Pharmacists Recommended designation” in the ... OTC brands, and is the only homeopathic formula ...
Breaking Biology Technology:Allegheny General Hospital Cardiovascular Institute Becomes Exclusive Pittsburgh Site for Study of Novel Coronary Artery Disease Device 2Allegheny General Hospital Cardiovascular Institute Becomes Exclusive Pittsburgh Site for Study of Novel Coronary Artery Disease Device 3Allegheny General Hospital Cardiovascular Institute Becomes Exclusive Pittsburgh Site for Study of Novel Coronary Artery Disease Device 4The International Congress on Personalized Medicine - Up Close and Personalized 2013 in Paris 2WMIS Appoints Lisa Baird as Next Executive Director 2Pharmacists' Picks: Topical BioMedics' Topricin Listed on Top Recommended OTC Health Products 2
... , - Books Authored by Noted ... Two of the biggest names in health care publishing, the ... to,co-publish International Classification of Diseases, Ninth Revision, Clinical,Modification (ICD-9-CM) and ... beginning with the 2010 editions, in fall 2009. , ...
... scientists have shown that amniotic fluid (the protective liquid ... of stem cells for therapeutic applications. The study was ... , the official journal of the American Society of ... research team wondered whether stem cells could be detected ...
... GENEVA, Switzerland, March 31 Viroblock SA ... VCCD Tech antiviral nasal spray,formulation is active ... Technology (VCCD Tech) inactivates enveloped,viruses during the ... envelopes. , The ...
Cached Biology Technology:The American Medical Association and Elsevier Join to Co-Publish ICD-9-CM and HCPCS Coding Reference Books 2The American Medical Association and Elsevier Join to Co-Publish ICD-9-CM and HCPCS Coding Reference Books 3Amniotic Fluid May Provide New Source of Stem Cells for Future Therapies 2Amniotic Fluid May Provide New Source of Stem Cells for Future Therapies 3Viroblock SA Reports Positive Results of Preclinical Studies in Antiviral Nasal Spray 2
(Date:5/16/2013)... Illustrating a commitment to the support of underrepresented ... Research Foundation has announced the inaugural AGA Investing ... Supported by the National Institute of Diabetes and ... helps underrepresented minority students to further their research ... "By establishing this new award, AGA demonstrates its ...
(Date:5/16/2013)... used ancient shorelines to predict the stability of today,s largest ... shoreline from three million years ago, for example when ... to be evidence of a high sea level due to ... many scientists to think that if the world,s largest ice ... the same in our modern, progressively warming world. , ...
(Date:5/16/2013)... Philadelphia, PA, May 16, 2013 The relationship ... intelligence (IQ) has not been clear. Schizophrenia is ... functional disability. There are clues that reduced IQ ... schizophrenia. For example, reduced cognitive ability may precede ... may be present in healthy relatives of people ...
Breaking Biology News(10 mins):Underrepresented minority students receive fellowships in digestive disease and nutrition research 2World's biggest ice sheets likely more stable than previously believed 2Genetic risk for schizophrenia is connected to reduced IQ 2
... has resulted in an exciting new method for rapidly and ... Recently completed testing by an independent European defence corporation ... per cent effective when used on the deadly nerve agents ... destruction of all three agents was achieved in less than ...
... research team from the Department of Genetics, Physical Anthropology ... Technology at the Leioa campus of the University of ... de la Ra, has reconstructed the history of the ... using DNA extracted from skeleton remains. Knowing the ...
... hold its 108th General Meeting June 1-5, 2008 ... over 3,000 individual scientific presentations spanning the breadth ... 12,000. Microbiologists study living organisms and infectious ... agriculture, the environment and biotechnology. Many accomplishments ...
Cached Biology News:Queen's develops safe 'green' decontamination method 2Ancient DNA: reconstruction of the biological history of Aldaieta necropolis 2Ancient DNA: reconstruction of the biological history of Aldaieta necropolis 3American Society for Microbiology 108th General Meeting 2